Complete Up To Date Information about Compudose 200.
NADA Number: 118-123 | |
| Proprietary Name |
Compudose® 200 Encore® (Compudose 400® ) |
|---|---|
| Sponsor |
Ivy Laboratories, Division of Ivy Animal Health, Inc. |
| Sponsor Address |
8857 Bond Street Overland Park, KS 66214 USA |
| Ingredients |
Oxytetracycline Estradiol |
| Species |
Cattle, beef, steers growing on pasture Cattle, beef, heifers fed in confinement for slaughter Cattle, beef, steers fed in confinement for slaughter Cattle, beef, steer calves, not weaned |
| Routes of Administration |
Subcutaneous |
| Dose Form |
Implant (pellet) |
| Drug Form |
Implant (pellet) |
| Dispensing Status |
OTC |
| Patent Number |
4191741 |
|
Dosage Amount, Indications & Limitations |
522.840 Estradiol. Specifications: Each silicone rubber implant contains 25.7 or 43.9 milligrams of estradioland is coated with not less than 0.5 milligrams oxytetracycline powder. Conditions of use: Cattle (suckling and pastured growing steers) Amount: Insert one 25.7-milligram implant every 200 days. Insert one 43.9-milligram implant every 400 days. Indications: For increased rate of weight gain in suckling and pastured growing steers. Limitations: No additional effectiveness may be expected from reimplanting in less than 200 days for the 25.7-milligram implant or 400 days for the 43.9-milligram implant. For subcutaneous ear implantation in steers and heifers only. Safety and effectiveness have not been established in veal calves. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal. Cattle (steers and heifers fed in confinement for slaughter) Amount: Insert one 25.7-milligram implant every 200 days. Insert one 43.9-milligram implant every 400 days. For subcutaneous ear implantation. Indications: For improved feed efficiency and increased rate of weight gain. Limitations: No additional effectiveness may be expected from reimplanting in less than 200 days for the 25.7-milligram implant or 400 days for the 43.9-milligram implant. For subcutaneous ear implantation in steers and heifers only. Safety and effectiveness have not been established in veal calves. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal. |
| Tolerances |
No residues of estradiol, resulting from the use of estradiol or any of the related esters, are permitted in excess of the following increments above the concentrations of estradiol naturally present in untreated animals: a. In uncooked edible tissues of heifers, steers, and calves: (1) 120 parts per trillion for muscle (2) 480 parts per trillion for fat (3) 360 parts per trillion for kidney (4) 240 parts per trillion for liver b. In uncooked edible tissues of lambs: (1) 120 parts per trillion for muscle (2) 600 parts per trillion for fat, kidney, and liver Beef cattle, dairy cattle, calves, swine, sheep, chickens, turkeys, finfish and lobster. Tolerances are established for the sum of residues of the tetracyclines including chlortetracycline, oxytetracycline, and tetracycline, in tissues and milk as follows: a. 2 parts per million (ppm) in muscle b. 6 ppm in liver c. 12 ppm in fat and kidney d. 0.3 ppm in milk. |